MiOncoSeq
The MiOncoSeq assay covers all or parts of over 1700 genes that have been implicated in cancer. The assay design consists of approximately 4.5 Mb of target sequence including exons of targeted genes as well as regions added for technical reasons. Sequence results are available for both tumor samples and matched normal samples. This approach enables the detection of point mutations, insertions/deletions, gene fusions and rearrangements, amplifications/deletions, and outlier expressed genes.